Object detection: A novel AI technology for the diagnosis of hepatocyte ballooning

Author:

Zheng Tian‐Lei12,Sha Jun‐Cheng3,Deng Qian4,Geng Shi2,Xiao Shu‐Yuan5,Yang Wen‐Jun6,Byrne Christopher D.7,Targher Giovanni89ORCID,Li Yang‐Yang10,Wang Xiang‐Xue11,Wu Di12,Zheng Ming‐Hua131415ORCID

Affiliation:

1. School of Information and Control Engineering China University of Mining and Technology Xuzhou China

2. Artificial Intelligence Unit, Department of Medical Equipment Management Affiliated Hospital of Xuzhou Medical University Xuzhou China

3. Department of Interventional Radiology Affiliated Hospital of Xuzhou Medical University Xuzhou China

4. Department of Histopathology Ningbo Clinical Pathology Diagnosis Center Ningbo China

5. Department of Pathology University of Chicago Medicine Chicago Illinois USA

6. Department of Pathology the Affiliated Hospital of Hangzhou Normal University Hangzhou China

7. Southampton National Institute for Health and Care Research Biomedical Research Centre University Hospital Southampton, Southampton General Hospital, and University of Southampton Southampton UK

8. Department of Medicine University of Verona Verona Italy

9. IRCSS Sacro Cuore – Don Calabria Hospital Negrar di Valpolicella Italy

10. Department of Pathology the First Affiliated Hospital of Wenzhou Medical University Wenzhou China

11. Institute for AI in Medicine, School of Artificial Intelligence Nanjing University of Information Science and Technology Nanjing China

12. Department of Pathology Xuzhou Central Hospital Xuzhou China

13. MAFLD Research Center, Department of Hepatology the First Affiliated Hospital of Wenzhou Medical University Wenzhou China

14. Institute of Hepatology Wenzhou Medical University Wenzhou China

15. Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province Wenzhou China

Abstract

AbstractMetabolic dysfunction‐associated fatty liver disease (MAFLD) has reached epidemic proportions worldwide and is the most frequent cause of chronic liver disease in developed countries. Within the spectrum of liver disease in MAFLD, steatohepatitis is a progressive form of liver disease and hepatocyte ballooning (HB) is a cardinal pathological feature of steatohepatitis. The accurate and reproducible diagnosis of HB is therefore critical for the early detection and treatment of steatohepatitis. Currently, a diagnosis of HB relies on pathological examination by expert pathologists, which may be a time‐consuming and subjective process. Hence, there has been interest in developing automated methods for diagnosing HB. This narrative review briefly discusses the development of artificial intelligence (AI) technology for diagnosing fatty liver disease pathology over the last 30 years and provides an overview of the current research status of AI algorithms for the identification of HB, including published articles on traditional machine learning algorithms and deep learning algorithms. This narrative review also provides a summary of object detection algorithms, including the principles, historical developments, and applications in the medical image analysis. The potential benefits of object detection algorithms for HB diagnosis (specifically those combined with a transformer architecture) are discussed, along with the future directions of object detection algorithms in HB diagnosis and the potential applications of generative AI on transformer architecture in this field. In conclusion, object detection algorithms have huge potential for the identification of HB and could make the diagnosis of MAFLD more accurate and efficient in the near future.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Reference108 articles.

1. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

2. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

3. Letter to the Editor: NAFLD, MAFLD or MASLD? Cut the Gordian knot with “Ludwig disease”

4. The heated debate over NAFLD renaming: an ongoing saga;Yilmaz Y;Hepatol Forum,2023

5. Insidious danger for young adults: metabolic (dysfunction)‐associated fatty liver disease;Kaya E;Hepatol Forum,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3